Vitamin K
Also called: phylloquinone, vitamin K1, phytonadione, menaquinone, vitamin K2, MK-4, MK-7
Fat-soluble compounds, phylloquinone (K1) and menaquinones (K2), that serve as coenzymes for proteins involved in blood clotting. K1 comes mainly from green leafy vegetables and vegetable oils; menaquinones mainly from fermented foods like natto, with smaller amounts in meat, dairy and eggs.
- Category
- Vitamin
- Forms
- Phylloquinone or phytonadione (K1); menaquinone-4 (MK-4) and menaquinone-7 (MK-7)
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2019 meta-analysis (Osteoporos Int) included 36 RCTs (11,112 participants) of oral vitamin K for bone density or fractures; controls received placebo, no treatment or the same co-therapy (calcium, vitamin D, hormones or bisphosphonates); 13 were placebo-controlled. [2]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CHeart and blood vessels1 topic
CHormones and reproduction1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Bone density and fractures in postmenopausal women | C | A 2019 meta-analysis of 36 RCTs, which excluded trials whose integrity was questioned, found no evidence that vitamin K affects bone density or vertebral fractures in postmenopausal or osteoporotic patients; fewer clinical fractures were possible but unconfirmed. [2] |
| Coronary artery calcification and heart disease | C | A 3-year RCT in 388 older adults (500 mcg phylloquinone) found no overall difference in calcification progression; cohort studies linked higher menaquinone intake to lower coronary heart disease mortality. [1] |
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- AI, adults 19+: men 120 mcg; women 90 mcg; pregnancy 90 mcg; lactation 90 mcg. [1]
- Trial amounts: MK-4 15 or 45 mg/day; MK-7 180 mcg/day for 3 years; phylloquinone 1 mg/day for 12 months or 500 mcg/day for 3 years. MK-4 at 45 mg is used as an osteoporosis treatment in Japan and other parts of Asia. [1]
- The American Academy of Pediatrics recommends a single intramuscular dose of 0.5 to 1 mg vitamin K1 at birth to address vitamin K deficiency bleeding. [1]
Upper limits
- No UL: vitamin K does not have a Tolerable Upper Intake Level because it has a low potential for toxicity. [1]
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter updated 2021-05-27: neither normal nor high doses have been …
Details and sources - Pregnancy and breastfeedingAdequate Intake 90 mcg/day in pregnancy and lactation (75 mcg/day at ages 14–18).
1 statement in the profile.
Details and sources - Interactions with medicines4 listed
Warfarin and similar anticoagulants (phenprocoumon, acenocoumarol, tioclomarol); Antibiotics; Bile acid sequestrants (cholestyramine, colestipol) …
Details and sources - Cancer evaluations (IARC, NTP)1 found
Each names the exact material tested, which may differ from a supplement.
Details and sources - FDA new dietary ingredient notifications5 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- The Food and Nutrition Board stated that no adverse effects of vitamin K from food or supplements have been reported in humans or animals. [1]
- Menadione (synthetic vitamin K3) damaged liver cells in laboratory studies and is no longer used in supplements or fortified foods. [1]
- People taking warfarin or similar anticoagulants need to maintain a consistent intake of vitamin K (see Interactions). [1]
- Groups at risk of inadequacy: newborns (vitamin K deficiency bleeding), people with malabsorption disorders, and people who have had bariatric surgery. [1]
Interactions
| With | What happens |
|---|---|
| Warfarin and similar anticoagulants | A serious and potentially dangerous interaction: sudden changes in vitamin K intake can alter the anticoagulant effect, so intake should be kept consistent. [1] |
| Antibiotics | Can reduce vitamin K-producing gut bacteria; cephalosporins such as cefoperazone may inhibit vitamin K's action. Supplements are usually not needed unless antibiotic use is prolonged and intake is poor. [1] |
| Bile acid sequestrants (cholestyramine, colestipol) | Can reduce absorption of vitamin K and other fat-soluble vitamins; the clinical significance is unclear, but ODS advises monitoring vitamin K status, especially with long-term use. [1] |
| Orlistat | Can reduce vitamin K absorption; combining orlistat with warfarin might significantly increase prothrombin time. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Free phylloquinone is about 80% absorbed, but the body absorbs only 4% to 17% as much phylloquinone from spinach as from a tablet. Phytonadione and MK-7 supplements are both well absorbed; MK-7 has a longer half-life. [1]
Regulatory status
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Phylloquinone (K1; phytonadione is the synthetic form) and menaquinones (K2), MK-4 through MK-13; supplements contain phylloquinone/phytonadione, MK-4 or MK-7 2-methyl-1,4-naphthoquinones [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 5 entries naming vitamin K (3) or menaquinone-7 dipropionate (2) (earliest NDI 500 submitted 2007-12-03; most recent NDI 1112 submitted 2019-05-29). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter updated 2021-05-27: neither normal nor high doses have been associated with ALT elevations or clinically apparent liver injury. [P5]
Interactions with medicines
- Warfarin and similar anticoagulants (phenprocoumon, acenocoumarol, tioclomarol): A serious and potentially dangerous interaction: these drugs antagonize vitamin K, so sudden changes in vitamin K intake can raise or lower the anticoagulant effect; consistent intake is needed. [P1]
- Antibiotics: Can destroy vitamin K-producing gut bacteria; cephalosporins such as cefoperazone may also inhibit vitamin K's action. [P1]
- Bile acid sequestrants (cholestyramine, colestipol): Can reduce absorption of vitamin K and other fat-soluble vitamins; clinical significance is unclear, but ODS advises monitoring vitamin K status, especially with long-term use. [P1]
- Orlistat: Reduces absorption of fat-soluble vitamins; combining orlistat with warfarin might significantly increase prothrombin time. [P1]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination of each component that is a dietary ingredient — Required by 21 CFR 111.75(a)(1)(i) for every dietary-ingredient component; an exemption may be requested by petition under 21 CFR 10.30. [P6]
Supply and conservation
- Phytonadione in supplements is synthetic; menadione (K3), also synthetic, is no longer used in supplements or fortified foods but can be used in poultry and swine feed. Dietary menaquinones are predominantly of bacterial origin. [P1]
Absorption in people
- Free phylloquinone is approximately 80% absorbed, but absorption from food is much lower: the body absorbs only 4% to 17% as much phylloquinone from spinach as from a tablet. Phytonadione and MK-7 supplements are both well absorbed; MK-7 has a longer half-life. [P1]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- Adequate Intake 90 mcg/day in pregnancy and lactation (75 mcg/day at ages 14–18). No Tolerable Upper Intake Level has been set because of low potential for toxicity. [P1]
Sources for this profile
- NIH Office of Dietary Supplements. Vitamin K: Fact Sheet for Health Professionals (updated October 22, 2026), 2026-10-22. ods.od.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. Agents Classified by the IARC Monographs: List of Classifications (accessed 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list (accessed 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- NIH LiverTox (NIDDK). Vitamin K (Last Update: 2021-05-27), 2021-05-27. ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources
- NIH Office of Dietary Supplements. Vitamin K: Fact Sheet for Health Professionals (updated October 22, 2026), 2026-10-22. ods.od.nih.gov
- Mott A, et al. Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials. Osteoporos Int 2019;30(8):1543-1559 (PMID 31076817; accepted manuscript read at eprints.whiterose.ac.uk/145682), 2019-05-10. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in vitamin: Benfotiamine · Biotin · Folate (folic acid) · Methylfolate (L-5-MTHF) · Niacin (vitamin B3) · Nicotinamide riboside · Pantothenic acid (vitamin B5) · Riboflavin (vitamin B2) · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.